Skip to main content
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025

Revenue by Product

Fiscal year is October - September.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Sep '24 Sep '23 Sep '22 Sep '21 Dec '19 2017 - 2019
Immuno-oncology Treatments
18.63K
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Treatments Growth
-87.40%
Log In
Log In
Log In
Log In
Upgrade
Restaurant
-
Log In
Log In
Log In
Log In
Upgrade
Franchise
-
Log In
Log In
Log In
Log In
Upgrade
Gaming
-
Log In
Log In
Log In
Log In
Upgrade
Management Fee Income
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Sep '24 Sep '23 Sep '22 Sep '21 Dec '19 2017 - 2019
United States
18.63K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-87.40%
Log In
Log In
Log In
Log In
Upgrade
United States and United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade